PTGER3 and central nervous system cancer: COX-2 and its product (PG) E2 interact with four GPCRs—PGE2 receptors like EP1, EP2, EP3, and EP4, and thereby enhance glioma aggressiveness by maintaining glioma cell stemness and the inflammatory microenvironment [32,33].